4-AcO-EPT
Pharmaceutical compound
From Wikipedia, the free encyclopedia
4-AcO-EPT, also known as 4-acetoxy-N-ethyl-N-propyltryptamine, is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to 4-AcO-DMT (psilacetin).[1][2] It is the acetate ester of 4-HO-EPT (eprocin) and is thought to act as a prodrug of 4-HO-EPT.[3][1][2] Based on online anecdotal reports, 4-AcO-EPT is said to have a dose of 20 to 30 mg orally.[1] It shows reduced affinity and agonistic potency at serotonin receptors, including the serotonin 5-HT2A receptor, compared to 4-HO-EPT.[3][4] Similarly to 4-HO-EPT, 4-AcO-EPT produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents, and does so with comparable potency, in line with it being a prodrug.[3] 4-AcO-EPT was encountered as a novel designer drug online in 2018, in Europe in 2020, and in the United States in 2021.[1][2]
- None
| Clinical data | |
|---|---|
| Other names | 4-Acetoxy-EPT; 4-Acetoxy-N-ethyl-N-propyltryptamine; 4-HO-EPT AC; 4-OH-EPT AC |
| Routes of administration | Oral[1] |
| Drug class | Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H24N2O2 |
| Molar mass | 288.391 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Society and culture
Legal status
Canada
4-AcO-EPT is not a controlled substance in Canada as of 2025.[5]